The Obesity Drug Loophole. Plus, the Outlook for Homebuilder

The Obesity Drug Loophole. Plus, the Outlook for Homebuilder Stocks.

Listen now

Description

Also, a top Vanguard strategist discusses the run-up in growth stocks. Learn more about your ad choices. Visit megaphone.fm/adchoices

More Episodes

See all »

Should Investors Worry About the U.S. National Debt?

Jonathan Pingle, Chief U.S. Economist at UBS, weighs in. Learn more about your ad choices. Visit megaphone.fm/adchoices

Published 09/20/24

Barron's Streetwise

Published 09/20/24

Nuclear, Crypto, and the A.I. Power Shortage

Stephen Byrd, the Global Head of Sustainability Research at Morgan Stanley, talks about investing in the watts needed to run tomorrow’s supercomputers. Learn more about your ad choices. Visit megaphone.fm/adchoices

Published 09/13/24